Skip to main content
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1999 Nov;36(11):801–818.

Genetic susceptibility to non-polyposis colorectal cancer

H Lynch 1, A de la Chapelle 1
PMCID: PMC1734258  PMID: 10544223

Abstract

Familial colorectal cancer (CRC) is a major public health problem by virtue of its relatively high frequency. Some 15-20% of all CRCs are familial. Among these, familial adenomatous polyposis (FAP), caused by germline mutations in the APC gene, accounts for less than 1%. Hereditary non-polyposis colorectal cancer (HNPCC), also called Lynch syndrome, accounts for approximately 5-8% of all CRC patients. Among these, some 3% are mutation positive, that is, caused by germline mutations in the DNA mismatch repair genes that have so far been implicated (MLH1, MSH2, MSH6, PMS1, and PMS2). Most of the remaining patients belonging to HNPCC or HNPCC-like families are still molecularly unexplained. Among the remaining familial CRCs, a large proportion is probably caused by gene mutations and polymorphisms of low penetrance, of which the I1307K polymorphism in the APC gene is a prime example.
Molecular genetic findings have enabled hereditary CRC to be divided into two groups: (1) tumours that show microsatellite instability (MSI), occur more frequently in the right colon, have diploid DNA, harbour characteristic mutations such as transforming growth factor β type II receptor and BAX, and behave indolently, of which HNPCC is an example; and (2) tumours with chromosomal instability (CIN), which tend to be left sided, show aneuploid DNA, harbour characteristic mutations such as K-ras, APC, and p53, and behave aggressively, of which FAP is an example.
This review focuses most heavily on the clinical features, pathology, molecular genetics, surveillance, and management including prophylactic surgery in HNPCC. Because of the difficulty in diagnosing HNPCC, a detailed differential diagnosis of the several hereditary CRC variants is provided. The extant genetic and phenotypic heterogeneity in CRC leads to the conclusion that it is no longer appropriate to discuss the genetics of CRC without defining the specific hereditary CRC syndrome of concern. Therefore, it is important to ascertain cancer of all anatomical sites, as well as non-cancer phenotypic stigmata (such as the perioral and mucosal pigmentations in Peutz-Jeghers syndrome), when taking a family cancer history.


Keywords: colorectal cancer; hereditary non-polyposis colorectal cancer; genetic susceptibility

Full Text

The Full Text of this article is available as a PDF (178.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaltonen L. A., Peltomäki P., Mecklin J. P., Järvinen H., Jass J. R., Green J. S., Lynch H. T., Watson P., Tallqvist G., Juhola M. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res. 1994 Apr 1;54(7):1645–1648. [PubMed] [Google Scholar]
  2. Aaltonen L. A., Salovaara R., Kristo P., Canzian F., Hemminki A., Peltomäki P., Chadwick R. B., Käriäinen H., Eskelinen M., Järvinen H. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med. 1998 May 21;338(21):1481–1487. doi: 10.1056/NEJM199805213382101. [DOI] [PubMed] [Google Scholar]
  3. Aaltonen L. A., Sankila R., Mecklin J. P., Järvinen H., Pukkala E., Peltomäki P., de la Chapelle A. A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden. Cancer Detect Prev. 1994;18(1):57–63. [PubMed] [Google Scholar]
  4. Aarnio M., Mecklin J. P., Aaltonen L. A., Nyström-Lahti M., Järvinen H. J. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer. 1995 Dec 20;64(6):430–433. doi: 10.1002/ijc.2910640613. [DOI] [PubMed] [Google Scholar]
  5. Aarnio M., Salovaara R., Aaltonen L. A., Mecklin J. P., Järvinen H. J. Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome. Int J Cancer. 1997 Oct 21;74(5):551–555. doi: 10.1002/(sici)1097-0215(19971021)74:5<551::aid-ijc13>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  6. Aarnio M., Salovaara R., Aaltonen L. A., Mecklin J. P., Järvinen H. J. Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome. Int J Cancer. 1997 Oct 21;74(5):551–555. doi: 10.1002/(sici)1097-0215(19971021)74:5<551::aid-ijc13>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  7. Aarnio M., Sankila R., Pukkala E., Salovaara R., Aaltonen L. A., de la Chapelle A., Peltomäki P., Mecklin J. P., Järvinen H. J. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer. 1999 Apr 12;81(2):214–218. doi: 10.1002/(sici)1097-0215(19990412)81:2<214::aid-ijc8>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  8. Abrahamson J., Moslehi R., Vesprini D., Karlan B., Fishman D., Smotkin D., Ben David Y., Biran H., Fields A., Brunet J. S. No association of the I1307K APC allele with ovarian cancer risk in Ashkenazi Jews. Cancer Res. 1998 Jul 15;58(14):2919–2922. [PubMed] [Google Scholar]
  9. Ahuja N., Li Q., Mohan A. L., Baylin S. B., Issa J. P. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res. 1998 Dec 1;58(23):5489–5494. [PubMed] [Google Scholar]
  10. Akiyama Y., Sato H., Yamada T., Nagasaki H., Tsuchiya A., Abe R., Yuasa Y. Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. Cancer Res. 1997 Sep 15;57(18):3920–3923. [PubMed] [Google Scholar]
  11. Ashley S. W., Wells S. A., Jr Tumors of the small intestine. Semin Oncol. 1988 Apr;15(2):116–128. [PubMed] [Google Scholar]
  12. Bapat B., Xia L., Madlensky L., Mitri A., Tonin P., Narod S. A., Gallinger S. The genetic basis of Muir-Torre syndrome includes the hMLH1 locus. Am J Hum Genet. 1996 Sep;59(3):736–739. [PMC free article] [PubMed] [Google Scholar]
  13. Bat L., Pines A., Ron E., Rosenblum Y., Niv Y., Shemesh E. Colorectal adenomatous polyps and carcinoma in Ashkenazi and non-Ashkenazi Jews in Israel. Cancer. 1986 Sep 1;58(5):1167–1171. doi: 10.1002/1097-0142(19860901)58:5<1167::aid-cncr2820580532>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  14. Baylin S. B., Herman J. G., Graff J. R., Vertino P. M., Issa J. P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res. 1998;72:141–196. [PubMed] [Google Scholar]
  15. Beck N. E., Tomlinson I. P., Homfray T. F., Frayling I. M., Hodgson S. V., Bodmer W. F. Frequency of germline hereditary non-polyposis colorectal cancer gene mutations in patients with multiple or early onset colorectal adenomas. Gut. 1997 Aug;41(2):235–238. doi: 10.1136/gut.41.2.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Beck N. E., Tomlinson I. P., Homfray T., Hodgson S. V., Harocopos C. J., Bodmer W. F. Genetic testing is important in families with a history suggestive of hereditary non-polyposis colorectal cancer even if the Amsterdam criteria are not fulfilled. Br J Surg. 1997 Feb;84(2):233–237. [PubMed] [Google Scholar]
  17. Bird R. P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 1987 Oct 30;37(2):147–151. doi: 10.1016/0304-3835(87)90157-1. [DOI] [PubMed] [Google Scholar]
  18. Bubb V. J., Curtis L. J., Cunningham C., Dunlop M. G., Carothers A. D., Morris R. G., White S., Bird C. C., Wyllie A. H. Microsatellite instability and the role of hMSH2 in sporadic colorectalcancer. Oncogene. 1996 Jun 20;12(12):2641–2649. [PubMed] [Google Scholar]
  19. Cannon-Albright L. A., Skolnick M. H., Bishop D. T., Lee R. G., Burt R. W. Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med. 1988 Sep 1;319(9):533–537. doi: 10.1056/NEJM198809013190902. [DOI] [PubMed] [Google Scholar]
  20. Cattanach B. M., Beechey C. V. Autosomal and X-chromosome imprinting. Dev Suppl. 1990:63–72. [PubMed] [Google Scholar]
  21. Church J. M. Prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer. Ann Med. 1996 Dec;28(6):479–482. doi: 10.3109/07853899608999111. [DOI] [PubMed] [Google Scholar]
  22. Church J. Hereditary colon cancers can be tiny: a cautionary case report of the results of colonoscopic surveillance. Am J Gastroenterol. 1998 Nov;93(11):2289–2290. doi: 10.1111/j.1572-0241.1998.00640.x. [DOI] [PubMed] [Google Scholar]
  23. Cohen P. R., Kohn S. R., Kurzrock R. Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. Am J Med. 1991 May;90(5):606–613. [PubMed] [Google Scholar]
  24. Cui H., Horon I. L., Ohlsson R., Hamilton S. R., Feinberg A. P. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med. 1998 Nov;4(11):1276–1280. doi: 10.1038/3260. [DOI] [PubMed] [Google Scholar]
  25. Cunningham J. M., Christensen E. R., Tester D. J., Kim C. Y., Roche P. C., Burgart L. J., Thibodeau S. N. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res. 1998 Aug 1;58(15):3455–3460. [PubMed] [Google Scholar]
  26. David K. L., Steiner-Grossman P. The potential use of tumor registry data in the recognition and prevention of hereditary and familial cancer. N Y State J Med. 1991 Apr;91(4):150–152. [PubMed] [Google Scholar]
  27. DeCosse J. J. Surgical prophylaxis of familial colon cancer: prevention of death from familial colorectal cancer. J Natl Cancer Inst Monogr. 1995;(17):31–32. [PubMed] [Google Scholar]
  28. Dunlop M. G., Farrington S. M., Carothers A. D., Wyllie A. H., Sharp L., Burn J., Liu B., Kinzler K. W., Vogelstein B. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet. 1997 Jan;6(1):105–110. doi: 10.1093/hmg/6.1.105. [DOI] [PubMed] [Google Scholar]
  29. Esteller M., Levine R., Baylin S. B., Ellenson L. H., Herman J. G. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Oncogene. 1998 Nov 5;17(18):2413–2417. doi: 10.1038/sj.onc.1202178. [DOI] [PubMed] [Google Scholar]
  30. Fearon E. R. Human cancer syndromes: clues to the origin and nature of cancer. Science. 1997 Nov 7;278(5340):1043–1050. doi: 10.1126/science.278.5340.1043. [DOI] [PubMed] [Google Scholar]
  31. Fleisher A. S., Esteller M., Wang S., Tamura G., Suzuki H., Yin J., Zou T. T., Abraham J. M., Kong D., Smolinski K. N. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res. 1999 Mar 1;59(5):1090–1095. [PubMed] [Google Scholar]
  32. Frayling I. M., Beck N. E., Ilyas M., Dove-Edwin I., Goodman P., Pack K., Bell J. A., Williams C. B., Hodgson S. V., Thomas H. J. The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history. Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10722–10727. doi: 10.1073/pnas.95.18.10722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Froggatt N. J., Green J., Brassett C., Evans D. G., Bishop D. T., Kolodner R., Maher E. R. A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer. J Med Genet. 1999 Feb;36(2):97–102. [PMC free article] [PubMed] [Google Scholar]
  34. Fujiwara T., Stolker J. M., Watanabe T., Rashid A., Longo P., Eshleman J. R., Booker S., Lynch H. T., Jass J. R., Green J. S. Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. Am J Pathol. 1998 Oct;153(4):1063–1078. doi: 10.1016/S0002-9440(10)65651-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Gibbs N. M. Undifferentiated carcinoma of the large intestine. Histopathology. 1977 Jan;1(1):77–84. doi: 10.1111/j.1365-2559.1977.tb01645.x. [DOI] [PubMed] [Google Scholar]
  36. Graham D. M., Appelman H. D. Crohn's-like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator. Mod Pathol. 1990 May;3(3):332–335. [PubMed] [Google Scholar]
  37. Greenwald P., Korns R. F., Nasca P. C., Wolfgang P. E. Cancer in United States Jews. Cancer Res. 1975 Nov;35(11 Pt 2):3507–3512. [PubMed] [Google Scholar]
  38. Gruber S. B., Petersen G. M., Kinzler K. W., Vogelstein B. Cancer, crash sites, and the new genetics of neoplasia. Gastroenterology. 1999 Jan;116(1):210–212. doi: 10.1016/s0016-5085(99)70246-5. [DOI] [PubMed] [Google Scholar]
  39. Gryfe R., Di Nicola N., Gallinger S., Redston M. Somatic instability of the APC I1307K allele in colorectal neoplasia. Cancer Res. 1998 Sep 15;58(18):4040–4043. [PubMed] [Google Scholar]
  40. Gryfe R., Di Nicola N., Lal G., Gallinger S., Redston M. Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism. Am J Hum Genet. 1999 Feb;64(2):378–384. doi: 10.1086/302262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Hackman P., Tannergård P., Osei-Mensa S., Chen J., Kane M. F., Kolodner R., Lambert B., Hellgren D., Lindblom A. A human compound heterozygote for two MLH1 missense mutations. Nat Genet. 1997 Oct;17(2):135–136. doi: 10.1038/ng1097-135. [DOI] [PubMed] [Google Scholar]
  42. Hamilton S. R., Liu B., Parsons R. E., Papadopoulos N., Jen J., Powell S. M., Krush A. J., Berk T., Cohen Z., Tetu B. The molecular basis of Turcot's syndrome. N Engl J Med. 1995 Mar 30;332(13):839–847. doi: 10.1056/NEJM199503303321302. [DOI] [PubMed] [Google Scholar]
  43. Heinen C. D., Shivapurkar N., Tang Z., Groden J., Alabaster O. Microsatellite instability in aberrant crypt foci from human colons. Cancer Res. 1996 Dec 1;56(23):5339–5341. [PubMed] [Google Scholar]
  44. Heinimann K., Müller H., Weber W., Scott R. J. Disease expression in Swiss hereditary non-polyposis colorectal cancer (HNPCC) kindreds. Int J Cancer. 1997 Jun 20;74(3):281–285. doi: 10.1002/(sici)1097-0215(19970620)74:3<281::aid-ijc8>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  45. Hemminki A., Peltomäki P., Mecklin J. P., Järvinen H., Salovaara R., Nyström-Lahti M., de la Chapelle A., Aaltonen L. A. Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer. Nat Genet. 1994 Dec;8(4):405–410. doi: 10.1038/ng1294-405. [DOI] [PubMed] [Google Scholar]
  46. Herman J. G., Umar A., Polyak K., Graff J. R., Ahuja N., Issa J. P., Markowitz S., Willson J. K., Hamilton S. R., Kinzler K. W. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6870–6875. doi: 10.1073/pnas.95.12.6870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Hiltunen M. O., Alhonen L., Koistinaho J., Myöhänen S., Päkkönen M., Marin S., Kosma V. M., Jänne J. Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma. Int J Cancer. 1997 Mar 17;70(6):644–648. doi: 10.1002/(sici)1097-0215(19970317)70:6<644::aid-ijc3>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  48. Hodgson S. V., Harocopos C., Gaglia P. Screening results in a family cancer clinic: five years experience. Anticancer Res. 1993 Nov-Dec;13(6B):2581–2585. [PubMed] [Google Scholar]
  49. Houlston R. S., Collins A., Slack J., Morton N. E. Dominant genes for colorectal cancer are not rare. Ann Hum Genet. 1992 May;56(Pt 2):99–103. doi: 10.1111/j.1469-1809.1992.tb01136.x. [DOI] [PubMed] [Google Scholar]
  50. Jass J. R. Colorectal adenoma progression and genetic change: is there a link? Ann Med. 1995 Jun;27(3):301–306. doi: 10.3109/07853899509002581. [DOI] [PubMed] [Google Scholar]
  51. Jass J. R., Smyrk T. C., Stewart S. M., Lane M. R., Lanspa S. J., Lynch H. T. Pathology of hereditary non-polyposis colorectal cancer. Anticancer Res. 1994 Jul-Aug;14(4B):1631–1634. [PubMed] [Google Scholar]
  52. Jass J. R., Stewart S. M. Evolution of hereditary non-polyposis colorectal cancer. Gut. 1992 Jun;33(6):783–786. doi: 10.1136/gut.33.6.783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Jones P. A., Laird P. W. Cancer epigenetics comes of age. Nat Genet. 1999 Feb;21(2):163–167. doi: 10.1038/5947. [DOI] [PubMed] [Google Scholar]
  54. Jäger A. C., Bisgaard M. L., Myrhøj T., Bernstein I., Rehfeld J. F., Nielsen F. C. Reduced frequency of extracolonic cancers in hereditary nonpolyposis colorectal cancer families with monoallelic hMLH1 expression. Am J Hum Genet. 1997 Jul;61(1):129–138. doi: 10.1086/513896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Järvinen H. J., Mecklin J. P., Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 1995 May;108(5):1405–1411. doi: 10.1016/0016-5085(95)90688-6. [DOI] [PubMed] [Google Scholar]
  56. Kane M. F., Loda M., Gaida G. M., Lipman J., Mishra R., Goldman H., Jessup J. M., Kolodner R. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 1997 Mar 1;57(5):808–811. [PubMed] [Google Scholar]
  57. Kim H., Jen J., Vogelstein B., Hamilton S. R. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol. 1994 Jul;145(1):148–156. [PMC free article] [PubMed] [Google Scholar]
  58. Kinzler K. W., Vogelstein B. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature. 1997 Apr 24;386(6627):761–763. doi: 10.1038/386761a0. [DOI] [PubMed] [Google Scholar]
  59. Kinzler K. W., Vogelstein B. Landscaping the cancer terrain. Science. 1998 May 15;280(5366):1036–1037. doi: 10.1126/science.280.5366.1036. [DOI] [PubMed] [Google Scholar]
  60. Kinzler K. W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996 Oct 18;87(2):159–170. doi: 10.1016/s0092-8674(00)81333-1. [DOI] [PubMed] [Google Scholar]
  61. Kolodner R. D., Hall N. R., Lipford J., Kane M. F., Rao M. R., Morrison P., Wirth L., Finan P. J., Burn J., Chapman P. Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations. Genomics. 1994 Dec;24(3):516–526. doi: 10.1006/geno.1994.1661. [DOI] [PubMed] [Google Scholar]
  62. Kruse R., Lamberti C., Wang Y., Ruelfs C., Bruns A., Esche C., Lehmann P., Ruzicka T., Rütten A., Friedl W. Is the mismatch repair deficient type of Muir-Torre syndrome confined to mutations in the hMSH2 gene? Hum Genet. 1996 Dec;98(6):747–750. doi: 10.1007/s004390050298. [DOI] [PubMed] [Google Scholar]
  63. Kruse R., Rütten A., Lamberti C., Hosseiny-Malayeri H. R., Wang Y., Ruelfs C., Jungck M., Mathiak M., Ruzicka T., Hartschuh W. Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet. 1998 Jul;63(1):63–70. doi: 10.1086/301926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Kune S., Kune G. A., Watson L. The Melbourne colorectal cancer study: incidence findings by age, sex, site, migrants and religion. Int J Epidemiol. 1986 Dec;15(4):483–493. doi: 10.1093/ije/15.4.483. [DOI] [PubMed] [Google Scholar]
  65. Laird P. W., Jackson-Grusby L., Fazeli A., Dickinson S. L., Jung W. E., Li E., Weinberg R. A., Jaenisch R. Suppression of intestinal neoplasia by DNA hypomethylation. Cell. 1995 Apr 21;81(2):197–205. doi: 10.1016/0092-8674(95)90329-1. [DOI] [PubMed] [Google Scholar]
  66. Laken S. J., Petersen G. M., Gruber S. B., Oddoux C., Ostrer H., Giardiello F. M., Hamilton S. R., Hampel H., Markowitz A., Klimstra D. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet. 1997 Sep;17(1):79–83. doi: 10.1038/ng0997-79. [DOI] [PubMed] [Google Scholar]
  67. Landis S. H., Murray T., Bolden S., Wingo P. A. Cancer statistics, 1998. CA Cancer J Clin. 1998 Jan-Feb;48(1):6–29. doi: 10.3322/canjclin.48.1.6. [DOI] [PubMed] [Google Scholar]
  68. Landis S. H., Murray T., Bolden S., Wingo P. A. Cancer statistics, 1999. CA Cancer J Clin. 1999 Jan-Feb;49(1):8-31, 1. doi: 10.3322/canjclin.49.1.8. [DOI] [PubMed] [Google Scholar]
  69. Lanspa S. J., Jenkins J. X., Cavalieri R. J., Smyrk T. C., Watson P., Lynch J., Lynch H. T. Surveillance in Lynch syndrome: how aggressive? Am J Gastroenterol. 1994 Nov;89(11):1978–1980. [PubMed] [Google Scholar]
  70. Leung S. Y., Yuen S. T., Chung L. P., Chu K. M., Chan A. S., Ho J. C. hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res. 1999 Jan 1;59(1):159–164. [PubMed] [Google Scholar]
  71. Lin K. M., Shashidharan M., Ternent C. A., Thorson A. G., Blatchford G. J., Christensen M. A., Lanspa S. J., Lemon S. J., Watson P., Lynch H. T. Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population. Dis Colon Rectum. 1998 Apr;41(4):428–433. doi: 10.1007/BF02235755. [DOI] [PubMed] [Google Scholar]
  72. Liu B., Nicolaides N. C., Markowitz S., Willson J. K., Parsons R. E., Jen J., Papadopolous N., Peltomäki P., de la Chapelle A., Hamilton S. R. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet. 1995 Jan;9(1):48–55. doi: 10.1038/ng0195-48. [DOI] [PubMed] [Google Scholar]
  73. Liu B., Parsons R., Papadopoulos N., Nicolaides N. C., Lynch H. T., Watson P., Jass J. R., Dunlop M., Wyllie A., Peltomäki P. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med. 1996 Feb;2(2):169–174. doi: 10.1038/nm0296-169. [DOI] [PubMed] [Google Scholar]
  74. Lothe R. A., Hektoen M., Johnsen H., Meling G. I., Andersen T. I., Rognum T. O., Lindblom A., Børresen-Dale A. L. The APC gene I1307K variant is rare in Norwegian patients with familial and sporadic colorectal or breast cancer. Cancer Res. 1998 Jul 15;58(14):2923–2924. [PubMed] [Google Scholar]
  75. Lothe R. A., Peltomäki P., Meling G. I., Aaltonen L. A., Nyström-Lahti M., Pylkkänen L., Heimdal K., Andersen T. I., Møller P., Rognum T. O. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res. 1993 Dec 15;53(24):5849–5852. [PubMed] [Google Scholar]
  76. Lu S. L., Kawabata M., Imamura T., Akiyama Y., Nomizu T., Miyazono K., Yuasa Y. HNPCC associated with germline mutation in the TGF-beta type II receptor gene. Nat Genet. 1998 May;19(1):17–18. doi: 10.1038/ng0598-17. [DOI] [PubMed] [Google Scholar]
  77. Lynch H. T., Follett K. L., Lynch P. M., Albano W. A., Mailliard J. L., Pierson R. L. Family history in an oncology clinic. Implications for cancer genetics. JAMA. 1979 Sep 21;242(12):1268–1272. [PubMed] [Google Scholar]
  78. Lynch H. T., Fusaro R. M., Roberts L., Voorhees G. J., Lynch J. F. Muir-Torre syndrome in several members of a family with a variant of the Cancer Family Syndrome. Br J Dermatol. 1985 Sep;113(3):295–301. doi: 10.1111/j.1365-2133.1985.tb02081.x. [DOI] [PubMed] [Google Scholar]
  79. Lynch H. T. Is there a role for prophylactic subtotal colectomy among hereditary nonpolyposis colorectal cancer germline mutation carriers? Dis Colon Rectum. 1996 Jan;39(1):109–110. doi: 10.1007/BF02048279. [DOI] [PubMed] [Google Scholar]
  80. Lynch H. T., Krush A. J. Cancer family "G" revisited: 1895-1970. Cancer. 1971 Jun;27(6):1505–1511. doi: 10.1002/1097-0142(197106)27:6<1505::aid-cncr2820270635>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  81. Lynch H. T., Lynch P. M., Pester J., Fusaro R. M. The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre's syndrome. Arch Intern Med. 1981 Apr;141(5):607–611. [PubMed] [Google Scholar]
  82. Lynch H. T., Shaw M. W., Magnuson C. W., Larsen A. L., Krush A. J. Hereditary factors in cancer. Study of two large midwestern kindreds. Arch Intern Med. 1966 Feb;117(2):206–212. [PubMed] [Google Scholar]
  83. Lynch H. T., Smyrk T. C. Identifying hereditary nonpolyposis colorectal cancer. N Engl J Med. 1998 May 21;338(21):1537–1538. doi: 10.1056/NEJM199805213382109. [DOI] [PubMed] [Google Scholar]
  84. Lynch H. T., Smyrk T. C., Watson P., Lanspa S. J., Lynch J. F., Lynch P. M., Cavalieri R. J., Boland C. R. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology. 1993 May;104(5):1535–1549. doi: 10.1016/0016-5085(93)90368-m. [DOI] [PubMed] [Google Scholar]
  85. Lynch H. T., Smyrk T. An update on Lynch syndrome. Curr Opin Oncol. 1998 Jul;10(4):349–356. doi: 10.1097/00001622-199807000-00012. [DOI] [PubMed] [Google Scholar]
  86. Lynch H. T., Smyrk T. Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer. 1996 Sep 15;78(6):1149–1167. doi: 10.1002/(SICI)1097-0142(19960915)78:6<1149::AID-CNCR1>3.0.CO;2-5. [DOI] [PubMed] [Google Scholar]
  87. Lynch H. T., Smyrk T., Lanspa S. J., Marcus J. N., Kriegler M., Lynch J. F., Appelman H. D. Flat adenomas in a colon cancer-prone kindred. J Natl Cancer Inst. 1988 Apr 20;80(4):278–282. doi: 10.1093/jnci/80.4.278. [DOI] [PubMed] [Google Scholar]
  88. Lynch H. T., Smyrk T., Lynch J. An update of HNPCC (Lynch syndrome). Cancer Genet Cytogenet. 1997 Jan;93(1):84–99. doi: 10.1016/s0165-4608(96)00290-7. [DOI] [PubMed] [Google Scholar]
  89. Lynch H. T., Smyrk T., McGinn T., Lanspa S., Cavalieri J., Lynch J., Slominski-Castor S., Cayouette M. C., Priluck I., Luce M. C. Attenuated familial adenomatous polyposis (AFAP). A phenotypically and genotypically distinctive variant of FAP. Cancer. 1995 Dec 15;76(12):2427–2433. doi: 10.1002/1097-0142(19951215)76:12<2427::aid-cncr2820761205>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  90. MCKUSICK V. A., HOSTETLER J. A., EGELAND J. A. GENETIC STUDIES OF THE AMISH, BACKGROUND AND POTENTIALITIES. Bull Johns Hopkins Hosp. 1964 Sep;115:203–222. [PubMed] [Google Scholar]
  91. Mecklin J. P., Järvinen H. J. Clinical features of colorectal carcinoma in cancer family syndrome. Dis Colon Rectum. 1986 Mar;29(3):160–164. doi: 10.1007/BF02555012. [DOI] [PubMed] [Google Scholar]
  92. Mecklin J. P., Järvinen H. J., Hakkiluoto A., Hallikas H., Hiltunen K. M., Härkönen N., Kellokumpu I., Laitinen S., Ovaska J., Tulikoura J. Frequency of hereditary nonpolyposis colorectal cancer. A prospective multicenter study in Finland. Dis Colon Rectum. 1995 Jun;38(6):588–593. doi: 10.1007/BF02054116. [DOI] [PubMed] [Google Scholar]
  93. Mecklin J. P., Järvinen H. J., Peltokallio P. Cancer family syndrome. Genetic analysis of 22 Finnish kindreds. Gastroenterology. 1986 Feb;90(2):328–333. [PubMed] [Google Scholar]
  94. Mecklin J. P., Järvinen H. J. Tumor spectrum in cancer family syndrome (hereditary nonpolyposis colorectal cancer). Cancer. 1991 Sep 1;68(5):1109–1112. doi: 10.1002/1097-0142(19910901)68:5<1109::aid-cncr2820680535>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  95. Miyaki M., Konishi M., Tanaka K., Kikuchi-Yanoshita R., Muraoka M., Yasuno M., Igari T., Koike M., Chiba M., Mori T. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet. 1997 Nov;17(3):271–272. doi: 10.1038/ng1197-271. [DOI] [PubMed] [Google Scholar]
  96. Modrich P. Mechanisms and biological effects of mismatch repair. Annu Rev Genet. 1991;25:229–253. doi: 10.1146/annurev.ge.25.120191.001305. [DOI] [PubMed] [Google Scholar]
  97. Moisio A. L., Sistonen P., Weissenbach J., de la Chapelle A., Peltomäki P. Age and origin of two common MLH1 mutations predisposing to hereditary colon cancer. Am J Hum Genet. 1996 Dec;59(6):1243–1251. [PMC free article] [PubMed] [Google Scholar]
  98. Moore J., Cowled P. Hereditary non-polyposis colorectal cancer syndrome. Aust N Z J Surg. 1999 Jan;69(1):6–13. doi: 10.1046/j.1440-1622.1999.01469.x. [DOI] [PubMed] [Google Scholar]
  99. Moslein G., Tester D. J., Lindor N. M., Honchel R., Cunningham J. M., French A. J., Halling K. C., Schwab M., Goretzki P., Thibodeau S. N. Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer. Hum Mol Genet. 1996 Sep;5(9):1245–1252. doi: 10.1093/hmg/5.9.1245. [DOI] [PubMed] [Google Scholar]
  100. Muir E. G., Bell A. J., Barlow K. A. Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face. Br J Surg. 1967 Mar;54(3):191–195. doi: 10.1002/bjs.1800540309. [DOI] [PubMed] [Google Scholar]
  101. Nyström-Lahti M., Kristo P., Nicolaides N. C., Chang S. Y., Aaltonen L. A., Moisio A. L., Järvinen H. J., Mecklin J. P., Kinzler K. W., Vogelstein B. Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nat Med. 1995 Nov;1(11):1203–1206. doi: 10.1038/nm1195-1203. [DOI] [PubMed] [Google Scholar]
  102. Nyström-Lahti M., Wu Y., Moisio A. L., Hofstra R. M., Osinga J., Mecklin J. P., Järvinen H. J., Leisti J., Buys C. H., de la Chapelle A. DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer. Hum Mol Genet. 1996 Jun;5(6):763–769. doi: 10.1093/hmg/5.6.763. [DOI] [PubMed] [Google Scholar]
  103. Papadopoulos N., Nicolaides N. C., Liu B., Parsons R., Lengauer C., Palombo F., D'Arrigo A., Markowitz S., Willson J. K., Kinzler K. W. Mutations of GTBP in genetically unstable cells. Science. 1995 Jun 30;268(5219):1915–1917. doi: 10.1126/science.7604266. [DOI] [PubMed] [Google Scholar]
  104. Peltomäki P. DNA mismatch repair gene mutations in human cancer. Environ Health Perspect. 1997 Jun;105 (Suppl 4):775–780. doi: 10.1289/ehp.105-1470030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Peltomäki P., de la Chapelle A. Mutations predisposing to hereditary nonpolyposis colorectal cancer. Adv Cancer Res. 1997;71:93–119. doi: 10.1016/s0065-230x(08)60097-4. [DOI] [PubMed] [Google Scholar]
  106. Percesepe A., Kristo P., Aaltonen L. A., Ponz de Leon M., de la Chapelle A., Peltomäki P. Mismatch repair genes and mononucleotide tracts as mutation targets in colorectal tumors with different degrees of microsatellite instability. Oncogene. 1998 Jul 16;17(2):157–163. doi: 10.1038/sj.onc.1201944. [DOI] [PubMed] [Google Scholar]
  107. Petrukhin L., Dangel J., Vanderveer L., Costalas J., Bellacosa A., Grana G., Daly M., Godwin A. K. The I1307K APC mutation does not predispose to colorectal cancer in Jewish Ashkenazi breast and breast-ovarian cancer kindreds. Cancer Res. 1997 Dec 15;57(24):5480–5484. [PubMed] [Google Scholar]
  108. Ponz de Leon M., Sassatelli R., Benatti P., Roncucci L. Identification of hereditary nonpolyposis colorectal cancer in the general population. The 6-year experience of a population-based registry. Cancer. 1993 Jun 1;71(11):3493–3501. doi: 10.1002/1097-0142(19930601)71:11<3493::aid-cncr2820711106>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  109. Ponz de Leon M., Sassatelli R., Sacchetti C., Zanghieri G., Scalmati A., Roncucci L. Familial aggregation of tumors in the three-year experience of a population-based colorectal cancer registry. Cancer Res. 1989 Aug 1;49(15):4344–4348. [PubMed] [Google Scholar]
  110. Prior T. W., Chadwick R. B., Papp A. C., Arcot A. N., Isa A. M., Pearl D. K., Stemmermann G., Percesepe A., Loukola A., Aaltonen L. A. The I1307K polymorphism of the APC gene in colorectal cancer. Gastroenterology. 1999 Jan;116(1):58–63. doi: 10.1016/s0016-5085(99)70229-5. [DOI] [PubMed] [Google Scholar]
  111. Rainier S., Johnson L. A., Dobry C. J., Ping A. J., Grundy P. E., Feinberg A. P. Relaxation of imprinted genes in human cancer. Nature. 1993 Apr 22;362(6422):747–749. doi: 10.1038/362747a0. [DOI] [PubMed] [Google Scholar]
  112. Redston M., Nathanson K. L., Yuan Z. Q., Neuhausen S. L., Satagopan J., Wong N., Yang D., Nafa D., Abrahamson J., Ozcelik H. The APCI1307K allele and breast cancer risk. Nat Genet. 1998 Sep;20(1):13–14. doi: 10.1038/1666. [DOI] [PubMed] [Google Scholar]
  113. Rex D. K., Cutler C. S., Lemmel G. T., Rahmani E. Y., Clark D. W., Helper D. J., Lehman G. A., Mark D. G. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology. 1997 Jan;112(1):24–28. doi: 10.1016/s0016-5085(97)70214-2. [DOI] [PubMed] [Google Scholar]
  114. Ricciardone M. D., Ozçelik T., Cevher B., Ozdağ H., Tuncer M., Gürgey A., Uzunalimoğlu O., Cetinkaya H., Tanyeli A., Erken E. Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. Cancer Res. 1999 Jan 15;59(2):290–293. [PubMed] [Google Scholar]
  115. Risch N., de Leon D., Ozelius L., Kramer P., Almasy L., Singer B., Fahn S., Breakefield X., Bressman S. Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population. Nat Genet. 1995 Feb;9(2):152–159. doi: 10.1038/ng0295-152. [DOI] [PubMed] [Google Scholar]
  116. Risinger J. I., Barrett J. C., Watson P., Lynch H. T., Boyd J. Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer. 1996 May 1;77(9):1836–1843. doi: 10.1002/(SICI)1097-0142(19960501)77:9<1836::AID-CNCR12>3.0.CO;2-0. [DOI] [PubMed] [Google Scholar]
  117. Rodriguez-Bigas M. A., Boland C. R., Hamilton S. R., Henson D. E., Jass J. R., Khan P. M., Lynch H., Perucho M., Smyrk T., Sobin L. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst. 1997 Dec 3;89(23):1758–1762. doi: 10.1093/jnci/89.23.1758. [DOI] [PubMed] [Google Scholar]
  118. Rodriguez-Bigas M. A., Vasen H. F., Lynch H. T., Watson P., Myrhøj T., Järvinen H. J., Mecklin J. P., Macrae F., St John D. J., Bertario L. Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma. International Collaborative Group on HNPCC. Cancer. 1998 Jul 15;83(2):240–244. doi: 10.1002/(sici)1097-0142(19980715)83:2<240::aid-cncr6>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  119. Rodríguez-Bigas M. A., Vasen H. F., Pekka-Mecklin J., Myrhøj T., Rozen P., Bertario L., Järvinen H. J., Jass J. R., Kunitomo K., Nomizu T. Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy. International Collaborative Group on HNPCC. Ann Surg. 1997 Feb;225(2):202–207. doi: 10.1097/00000658-199702000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Roncucci L., Modica S., Pedroni M., Tamassia M. G., Ghidoni M., Losi L., Fante R., Di Gregorio C., Manenti A., Gafa L. Aberrant crypt foci in patients with colorectal cancer. Br J Cancer. 1998 Jun;77(12):2343–2348. doi: 10.1038/bjc.1998.389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Roncucci L., Stamp D., Medline A., Cullen J. B., Bruce W. R. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol. 1991 Mar;22(3):287–294. doi: 10.1016/0046-8177(91)90163-j. [DOI] [PubMed] [Google Scholar]
  122. Rozen P., Shomrat R., Strul H., Naiman T., Karminsky N., Legum C., Orr-Urtreger A. Prevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer. Gastroenterology. 1999 Jan;116(1):54–57. doi: 10.1016/s0016-5085(99)70228-3. [DOI] [PubMed] [Google Scholar]
  123. Rüschoff J., Wallinger S., Dietmaier W., Bocker T., Brockhoff G., Hofstädter F., Fishel R. Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection. Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11301–11306. doi: 10.1073/pnas.95.19.11301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Sankila R., Aaltonen L. A., Järvinen H. J., Mecklin J. P. Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology. 1996 Mar;110(3):682–687. doi: 10.1053/gast.1996.v110.pm8608876. [DOI] [PubMed] [Google Scholar]
  125. Sapienza C., Paquette J., Tran T. H., Peterson A. Epigenetic and genetic factors affect transgene methylation imprinting. Development. 1989 Sep;107(1):165–168. doi: 10.1242/dev.107.1.165. [DOI] [PubMed] [Google Scholar]
  126. Senba S., Konishi F., Okamoto T., Kashiwagi H., Kanazawa K., Miyaki M., Konishi M., Tsukamoto T. Clinicopathologic and genetic features of nonfamilial colorectal carcinomas with DNA replication errors. Cancer. 1998 Jan 15;82(2):279–285. [PubMed] [Google Scholar]
  127. Shimodaira H., Filosi N., Shibata H., Suzuki T., Radice P., Kanamaru R., Friend S. H., Kolodner R. D., Ishioka C. Functional analysis of human MLH1 mutations in Saccharomyces cerevisiae. Nat Genet. 1998 Aug;19(4):384–389. doi: 10.1038/1277. [DOI] [PubMed] [Google Scholar]
  128. Smyrk T. C., Lynch H. T. Microsatellite instability: impact on cancer progression in proximal and distal colorectal cancers. Eur J Cancer. 1999 Feb;35(2):171–172. doi: 10.1016/s0959-8049(98)00380-3. [DOI] [PubMed] [Google Scholar]
  129. Spirio L., Olschwang S., Groden J., Robertson M., Samowitz W., Joslyn G., Gelbert L., Thliveris A., Carlson M., Otterud B. Alleles of the APC gene: an attenuated form of familial polyposis. Cell. 1993 Dec 3;75(5):951–957. doi: 10.1016/0092-8674(93)90538-2. [DOI] [PubMed] [Google Scholar]
  130. Storey A., Thomas M., Kalita A., Harwood C., Gardiol D., Mantovani F., Breuer J., Leigh I. M., Matlashewski G., Banks L. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature. 1998 May 21;393(6682):229–234. doi: 10.1038/30400. [DOI] [PubMed] [Google Scholar]
  131. Syngal S., Weeks J. C., Schrag D., Garber J. E., Kuntz K. M. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Ann Intern Med. 1998 Nov 15;129(10):787–796. doi: 10.7326/0003-4819-129-10-199811150-00007. [DOI] [PubMed] [Google Scholar]
  132. Takayama T., Katsuki S., Takahashi Y., Ohi M., Nojiri S., Sakamaki S., Kato J., Kogawa K., Miyake H., Niitsu Y. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med. 1998 Oct 29;339(18):1277–1284. doi: 10.1056/NEJM199810293391803. [DOI] [PubMed] [Google Scholar]
  133. Thibodeau S. N., French A. J., Roche P. C., Cunningham J. M., Tester D. J., Lindor N. M., Moslein G., Baker S. M., Liskay R. M., Burgart L. J. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res. 1996 Nov 1;56(21):4836–4840. [PubMed] [Google Scholar]
  134. Tomlinson I., Rahman N., Frayling I., Mangion J., Barfoot R., Hamoudi R., Seal S., Northover J., Thomas H. J., Neale K. Inherited susceptibility to colorectal adenomas and carcinomas: evidence for a new predisposition gene on 15q14-q22. Gastroenterology. 1999 Apr;116(4):789–795. doi: 10.1016/s0016-5085(99)70061-2. [DOI] [PubMed] [Google Scholar]
  135. Torre D. Multiple sebaceous tumors. Arch Dermatol. 1968 Nov;98(5):549–551. doi: 10.1001/archderm.98.5.549. [DOI] [PubMed] [Google Scholar]
  136. Vasen H. F., Mecklin J. P., Khan P. M., Lynch H. T. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum. 1991 May;34(5):424–425. doi: 10.1007/BF02053699. [DOI] [PubMed] [Google Scholar]
  137. Vasen H. F., Nagengast F. M., Khan P. M. Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome) Lancet. 1995 May 6;345(8958):1183–1184. doi: 10.1016/s0140-6736(95)91016-6. [DOI] [PubMed] [Google Scholar]
  138. Vasen H. F., Wijnen J. T., Menko F. H., Kleibeuker J. H., Taal B. G., Griffioen G., Nagengast F. M., Meijers-Heijboer E. H., Bertario L., Varesco L. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology. 1996 Apr;110(4):1020–1027. doi: 10.1053/gast.1996.v110.pm8612988. [DOI] [PubMed] [Google Scholar]
  139. Vasen H. F., van Ballegooijen M., Buskens E., Kleibeuker J. K., Taal B. G., Griffioen G., Nagengast F. M., Menko F. H., Meera Khan P. A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers. Cancer. 1998 May 1;82(9):1632–1637. [PubMed] [Google Scholar]
  140. Veigl M. L., Kasturi L., Olechnowicz J., Ma A. H., Lutterbaugh J. D., Periyasamy S., Li G. M., Drummond J., Modrich P. L., Sedwick W. D. Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8698–8702. doi: 10.1073/pnas.95.15.8698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Wang Q., Lasset C., Desseigne F., Frappaz D., Bergeron C., Navarro C., Ruano E., Puisieux A. Neurofibromatosis and early onset of cancers in hMLH1-deficient children. Cancer Res. 1999 Jan 15;59(2):294–297. [PubMed] [Google Scholar]
  142. Watson P., Lin K. M., Rodriguez-Bigas M. A., Smyrk T., Lemon S., Shashidharan M., Franklin B., Karr B., Thorson A., Lynch H. T. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer. 1998 Jul 15;83(2):259–266. [PubMed] [Google Scholar]
  143. Watson P., Lynch H. T. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer. 1993 Feb 1;71(3):677–685. doi: 10.1002/1097-0142(19930201)71:3<677::aid-cncr2820710305>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  144. White R. L. Excess risk of colon cancer associated with a polymorphism of the APC gene? Cancer Res. 1998 Sep 15;58(18):4038–4039. [PubMed] [Google Scholar]
  145. White S., Bubb V. J., Wyllie A. H. Germline APC mutation (Gln1317) in a cancer-prone family that does not result in familial adenomatous polyposis. Genes Chromosomes Cancer. 1996 Feb;15(2):122–128. doi: 10.1002/(SICI)1098-2264(199602)15:2<122::AID-GCC7>3.0.CO;2-5. [DOI] [PubMed] [Google Scholar]
  146. Wijnen J., Khan P. M., Vasen H., van der Klift H., Mulder A., van Leeuwen-Cornelisse I., Bakker B., Losekoot M., Møller P., Fodde R. Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations. Am J Hum Genet. 1997 Aug;61(2):329–335. doi: 10.1086/514847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Wijnen J., van der Klift H., Vasen H., Khan P. M., Menko F., Tops C., Meijers Heijboer H., Lindhout D., Møller P., Fodde R. MSH2 genomic deletions are a frequent cause of HNPCC. Nat Genet. 1998 Dec;20(4):326–328. doi: 10.1038/3795. [DOI] [PubMed] [Google Scholar]
  148. Woodage T., King S. M., Wacholder S., Hartge P., Struewing J. P., McAdams M., Laken S. J., Tucker M. A., Brody L. C. The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat Genet. 1998 Sep;20(1):62–65. doi: 10.1038/1722. [DOI] [PubMed] [Google Scholar]
  149. Wu Y., Nyström-Lahti M., Osinga J., Looman M. W., Peltomäki P., Aaltonen L. A., de la Chapelle A., Hofstra R. M., Buys C. H. MSH2 and MLH1 mutations in sporadic replication error-positive colorectal carcinoma as assessed by two-dimensional DNA electrophoresis. Genes Chromosomes Cancer. 1997 Apr;18(4):269–278. [PubMed] [Google Scholar]
  150. de Wind N., Dekker M., van Rossum A., van der Valk M., te Riele H. Mouse models for hereditary nonpolyposis colorectal cancer. Cancer Res. 1998 Jan 15;58(2):248–255. [PubMed] [Google Scholar]
  151. de la Chapelle A. Disease gene mapping in isolated human populations: the example of Finland. J Med Genet. 1993 Oct;30(10):857–865. doi: 10.1136/jmg.30.10.857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. de la Chapelle A., Peltomäki P. Genetics of hereditary colon cancer. Annu Rev Genet. 1995;29:329–348. doi: 10.1146/annurev.ge.29.120195.001553. [DOI] [PubMed] [Google Scholar]
  153. de la Chapelle A., Wright F. A. Linkage disequilibrium mapping in isolated populations: the example of Finland revisited. Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12416–12423. doi: 10.1073/pnas.95.21.12416. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Appendix]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES